Aude IDRIS
Lawyer
Aude Idris holds a Master 2 in Business Law and Corporate Taxation (University of Bordeaux IV, 2006).
Aude began her career in 2007 in the corporate department of the legal department of an accounting and auditing firm in Bordeaux as a lawyer, before joining Sébastien Péronne's team in the law firm Fidal lawyers in Bordeaux in 2012. In 2017, she joined Brunswick Avocats and joined Altaïr Avocats in January 2019.
She works in private equity and mergers and acquisitions, and more generally in corporate law. She provides legal follow-up and participates in audits and transactional operations for a large portfolio of companies.
Aude began her career in 2007 in the corporate department of the legal department of an accounting and auditing firm in Bordeaux as a lawyer, before joining Sébastien Péronne's team in the law firm Fidal lawyers in Bordeaux in 2012. In 2017, she joined Brunswick Avocats and joined Altaïr Avocats in January 2019.
She works in private equity and mergers and acquisitions, and more generally in corporate law. She provides legal follow-up and participates in audits and transactional operations for a large portfolio of companies.
Areas of expertise :
- Corporate
- Capital Investment
- LBO
- Mergers and acquisitions
Deals, Publications and Seminars :
- Groupe Alliance Étiquettes acquires Imprimerie de l'Eperon
- Groupe Alliance Étiquettes acquires Impressions de L'Enclos from Advini
- REBRAIN raises 3.7 million euros to support the fight against parkinson's disease
- Conseil d'Easy Live et ses fondateurs ( Philippe Laurent, Clément Sanchez et Nicolas Ehrmann) à l’occasion de sa levée de fonds de 2,1M€
- Conseil de TreeFrog Therapeutics à l’occasion de sa levée de fonds de 7,1 M€ en Série A
- Conseil des associés de Léon Vincent Overseas dans le cadre de sa cession à 21 Capital Partners
- Conseil des associés de Medgest dans le cadre de la cession de leur participation à Verso Healthcare
- Conseil de GSO Capital et Charente Périgord Expansion dans leur investissement dans Altiore MT / Informatique
- Conseil de LNC Therapeutics et sa direction générale à l’occasion de sa levée de fonds de 6.2M€.